Rubius Therapeutics, Inc.

OTCPK:RUBY Stock Report

Market Cap: US$5.2m

Rubius Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of RUBY?
Owner TypeNumber of SharesOwnership Percentage
Private Companies180,0000.199%
Institutions448,5660.496%
Individual Insiders4,837,3285.35%
General Public85,017,05794%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 9 shareholders own 5.88% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.22%
David Epstein
4,720,012US$269.0k0%no data
0.33%
FMR LLC
298,019US$17.0k0%no data
0.2%
Three Opinions Foundation Inc.
180,000US$10.3k0%no data
0.073%
Pablo Cagnoni
66,082US$3.8k0%no data
0.028%
Jonathan Symonds
25,000US$1.4k0%no data
0.02%
Laurence Turka
18,391US$1.0k0%no data
0.0059%
Maiken Keson-Brookes
5,343US$304.30%no data
0.0028%
Catherine Sohn
2,500US$142.30%no data
0.0006%
Guggenheim Partners, LLC
547US$30.90%no data